REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $60,506,155 | +21.1% | 593,430 | +8.0% | 0.01% | +16.7% |
| Q1 2023 | $49,943,569 | +249780.3% | 549,313 | +4.4% | 0.01% | +100.0% |
| Q4 2022 | $19,987 | -99.8% | 526,116 | +4.4% | 0.00% | +50.0% |
| Q3 2022 | $12,663,000 | -15.3% | 503,920 | +2.5% | 0.00% | 0.0% |
| Q2 2022 | $14,947,000 | +1.2% | 491,865 | +9.1% | 0.00% | 0.0% |
| Q1 2022 | $14,772,000 | +21.1% | 450,922 | -2.5% | 0.00% | +100.0% |
| Q4 2021 | $12,198,000 | -74.6% | 462,581 | -3.2% | 0.00% | -83.3% |
| Q3 2021 | $48,074,000 | -28.7% | 477,832 | +0.3% | 0.01% | -33.3% |
| Q2 2021 | $67,430,000 | +101.3% | 476,443 | +41.8% | 0.01% | +80.0% |
| Q1 2021 | $33,503,000 | -14.2% | 336,041 | +6.4% | 0.01% | -28.6% |
| Q4 2020 | $39,029,000 | +42.4% | 315,722 | +12.2% | 0.01% | +40.0% |
| Q3 2020 | $27,406,000 | -43.0% | 281,322 | -8.8% | 0.01% | -50.0% |
| Q2 2020 | $48,102,000 | -9.1% | 308,307 | -15.9% | 0.01% | -28.6% |
| Q1 2020 | $52,927,000 | -61.8% | 366,684 | -45.9% | 0.01% | 0.0% |
| Q4 2019 | $138,652,000 | +487.5% | 678,244 | +130.7% | 0.01% | +133.3% |
| Q3 2019 | $23,601,000 | +3.8% | 293,953 | +21.9% | 0.01% | 0.0% |
| Q2 2019 | $22,742,000 | +23.2% | 241,049 | +11.6% | 0.01% | +20.0% |
| Q1 2019 | $18,462,000 | -14.4% | 216,006 | -43.8% | 0.01% | +66.7% |
| Q4 2018 | $21,576,000 | +45.5% | 384,612 | +112.1% | 0.00% | -25.0% |
| Q3 2018 | $14,827,000 | +199.8% | 181,348 | +28.2% | 0.00% | +100.0% |
| Q2 2018 | $4,945,000 | +111.1% | 141,422 | +23.8% | 0.00% | +100.0% |
| Q1 2018 | $2,342,000 | -27.5% | 114,231 | +0.1% | 0.00% | 0.0% |
| Q4 2017 | $3,232,000 | +8.3% | 114,148 | +18.9% | 0.00% | 0.0% |
| Q3 2017 | $2,985,000 | +38.1% | 96,006 | +40.5% | 0.00% | 0.0% |
| Q2 2017 | $2,161,000 | +49.7% | 68,320 | +7.1% | 0.00% | 0.0% |
| Q1 2017 | $1,444,000 | +23.9% | 63,778 | +19.5% | 0.00% | 0.0% |
| Q4 2016 | $1,165,000 | -16.0% | 53,381 | +1.4% | 0.00% | 0.0% |
| Q3 2016 | $1,387,000 | – | 52,623 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |